share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  05/31 10:58

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月31日出售2,250股普通股,總市值約爲1,001,250美元。這些股票是通過限制性股票歸屬作爲補償的一部分在兩個不同的場合收購的,其中1,422股於2024年2月17日歸屬,2024年2月24日又收購了828股,均來自發行人。此次計劃出售遵循了最近的交易記錄,塔西斯在過去三個月中出售了2350股股票,總收益爲1,031,908.5美元。
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月31日出售2,250股普通股,總市值約爲1,001,250美元。這些股票是通過限制性股票歸屬作爲補償的一部分在兩個不同的場合收購的,其中1,422股於2024年2月17日歸屬,2024年2月24日又收購了828股,均來自發行人。此次計劃出售遵循了最近的交易記錄,塔西斯在過去三個月中出售了2350股股票,總收益爲1,031,908.5美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息